125 related articles for article (PubMed ID: 7428359)
1. Selected events following insertion of the Progestasert system.
Gibor Y; Mitchell C
Contraception; 1980 May; 21(5):491-503. PubMed ID: 7428359
[TBL] [Abstract][Full Text] [Related]
2. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
Custo GM; Cosmi EV
Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
[TBL] [Abstract][Full Text] [Related]
3. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
Newton J; Szontagh F; Lebech P; Rowe P
Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
[TBL] [Abstract][Full Text] [Related]
4. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
Stanback J; Grimes D
Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.
Pizarro E; Gomez-Rogers C; Rowe PJ
Contraception; 1979 Nov; 20(5):455-66. PubMed ID: 527341
[TBL] [Abstract][Full Text] [Related]
6. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with the uterine progesterone system (Progestasert R).
Zador G; Nilsson BA; Nilsson B; Sjöberg NO; Weström L; Wiese J
Contraception; 1976 May; 13(5):559-69. PubMed ID: 1261259
[TBL] [Abstract][Full Text] [Related]
8. Postpartum IUDS: keys for success.
O'Hanley K; Huber DH
Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
Lavin P; Waszak C; Bravo C
Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
[TBL] [Abstract][Full Text] [Related]
10. Comparison between two IUDs: Progestasert and CuT 200.
Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
[TBL] [Abstract][Full Text] [Related]
11. [The Progestasert system].
Mall-Haefeli M
Gynakol Rundsch; 1978; 18(3-4):253-62. PubMed ID: 569628
[TBL] [Abstract][Full Text] [Related]
12. Five years private practice experience of nulliparous women using copper IUD's.
Smith RP; Goresky DM; Etchell DM
Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Progestasert on the menstrual pattern, ovarian steroids and endometrium.
Wan LS; Hsu YC; Ganguly M; Bigelow B
Contraception; 1977 Oct; 16(4):417-34. PubMed ID: 923252
[TBL] [Abstract][Full Text] [Related]
14. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.
Fylling P; Fagerhol M
Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675
[TBL] [Abstract][Full Text] [Related]
15. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
16. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
17. [Contraception with the intrauterine pessary Progestasert].
Schweppe KW; Tenhaeff D; Rache D
Fortschr Med; 1978 Sep; 96(33):1685-90. PubMed ID: 700553
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
20. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
